Search
Korro Bio CEO on RNA editing and the process behind reverse mergers
- blonca9
- Jul 17, 2023
- 1 min read
Ram Aiyar discusses RNA editing and the news announced Friday that his company Korro Bio is aiming to do a reverse merge to go public.
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.